HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017
Period Ending	Jan '26 Jan 16, 2026	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	238,157	75,194	58,507	80,206
Market Cap Growth	-27.52%	28.52%	-27.05%	-
Enterprise Value	228,503	77,595	-	-
Last Close Price	16960.00	5430.00	4225.00	6420.00
PE Ratio	503.87	159.09	-	-
PS Ratio	6.60	2.08	2.85	5.16
PB Ratio	13.30	4.20	3.44	4.77
P/TBV Ratio	13.64	4.31	3.50	4.83
P/OCF Ratio	175.98	55.56	-	-
EV/Sales Ratio	6.33	2.15	-	-
EV/EBITDA Ratio	74.17	25.19	-	-
EV/EBIT Ratio	158.58	53.85	-	-
Debt / Equity Ratio	0.74	0.74	0.45	0.89
Debt / EBITDA Ratio	4.28	4.28	-	-
Asset Turnover	0.88	0.88	0.54	-
Inventory Turnover	3.27	3.27	3.13	-
Quick Ratio	1.01	1.01	0.94	1.01
Current Ratio	1.26	1.26	1.31	1.31
Return on Equity (ROE)	2.71%	2.71%	-41.77%	-
Return on Assets (ROA)	2.19%	2.19%	-9.55%	-
Return on Invested Capital (ROIC)	3.23%	3.23%	-12.90%	-
Return on Capital Employed (ROCE)	6.30%	6.30%	-28.80%	-17.40%
Earnings Yield	0.20%	0.63%	-12.07%	-6.79%
FCF Yield	-0.02%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-2.30%	-2.30%	-13.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.